TheAustralia & New Zealand dental biomaterials marketsize is expected to reach USD 48.3 million by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.6% from 2020 to 2027.Dental biomaterialsinclude the biocompatible synthetic materials and natural tissues that are used to restore damaged, decayed, or fractured teeth. There are different types of natural dental tissues, such as dentin, enamel, bone, cementum, and other intraoral tissues. These dental tissues are used in the treatment of various dental diseases. With the increasing prevalence of various oral diseases, the demand for dental biomaterials is also increasing. Hence, the market is estimated to witness lucrative growth over the forecast period.
The increasing prevalence of oral diseases, the rising dental tourism in emerging countries, and the growing geriatric population are some of the major factors driving the market. According to the survey carried out by the Australian Institute of Health and Welfare in 2019, oral health contributes to 4.5% of all the burden diseases, such as gum disease, tooth decay, and tooth loss. Oral diseases are the most expensive diseases to be treated in developed as well as developing countries. The dental biomaterials accounted for 5.0% of the overall health expenditure in developed countries, like Australia. Dental biomaterials are promising products and have a high success rate in oral prevention and treatment. This factor is anticipated to boost the growth of the market over the forecast period.
Increasing the edentulous population is also one of the reasons responsible for market growth. The promptly increasing number of qualified dental professionals is anticipated to increase access to dental care. Australia held the largest share of over 65.0% in 2019 due to its technological improvement in dental biomaterials, rising aging population, and increasing investment in R&D. Moreover, the growing collaborations between hospitals and academic institutions, widespread R&D activities at the industrial and academic levels, and increase in the application scope of dental biomaterials, such as orthodontics and implantology, have fueled the market growth over the forecast period. Furthermore, the presence of major players has contributed to market growth.
Request a free sample copy or view report summary:Australia & New Zealand Dental Biomaterials Market Report
By type, the metallic biomaterials segment dominated the market in 2019 with a share of 34.8% owing to the increasing prevalence of dental diseases and the rising demand for dental biomaterials in developing countries
The ceramic biomaterials type segment is anticipated to register the fastest CAGR of 9.1% over the forecast period
The implantology application segment accounted for the largest share of 43.1% in 2019 and is anticipated to maintain its lead owing to growing dental problems
Australia held the largest share of over 65.0% in 2019. This can be attributed to the rapid increase in the development of dental biomaterials to meet the growing demand for efficient healthcare in the country
Grand View Research has segmented the Australia & New Zealand dental biomaterials market based on type, application, end-use, and region:
Australia & New Zealand Dental Biomaterials Type Outlook (Revenue, USD Million, 2016 - 2027)
Metallic Biomaterials
Ceramic Biomaterials
Polymeric Biomaterials
Metal-ceramic Biomaterials
Natural Biomaterials
Composites Biomaterials
Australia & New Zealand Dental Biomaterials Application Outlook (Revenue, USD Million, 2016 - 2027)
Orthodontics
Implantology
假牙修复术
Others
Australia & New Zealand Dental Biomaterials End-use Outlook (Revenue, USD Million, 2016 - 2027)
Dental Hospitals and Clinics
Dental Laboratories
Dental Academies and Research Institutes
Australia & New Zealand Dental Biomaterials Regional Outlook (Revenue, USD Million, 2016 - 2027)
Australia
New Zealand
List of Key Players of Australia & New Zealand Dental Biomaterials Market
Straumann Holding AG
Geistlich制药公司
Zimmer Biomet Holding, Inc.
Danaher Corporation
Dentsply Sirona, Inc.
3M Company
皇家帝
Carpenter Technology Corporation
Kuraray Co. Ltd.
Medtronic
Henry Schein
Ivoclar Vivadent AG
"The quality of research they have done for us has been excellent..."